Medtronic Plc (MDT)
88.00
+1.62
(+1.88%)
USD |
NYSE |
Oct 05, 16:00
88.07
+0.07
(+0.08%)
After-Hours: 20:00
Medtronic Enterprise Value : 130.52B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 130.52B |
| October 01, 2026 | 130.60B |
| September 30, 2026 | 130.41B |
| September 29, 2026 | 131.43B |
| September 28, 2026 | 134.52B |
| September 25, 2026 | 133.42B |
| September 24, 2026 | 133.25B |
| September 23, 2026 | 134.26B |
| September 22, 2026 | 136.14B |
| September 21, 2026 | 137.40B |
| September 18, 2026 | 137.88B |
| September 17, 2026 | 138.70B |
| September 16, 2026 | 138.48B |
| September 15, 2026 | 139.96B |
| September 14, 2026 | 140.02B |
| September 11, 2026 | 136.39B |
| September 10, 2026 | 137.23B |
| September 09, 2026 | 137.58B |
| September 08, 2026 | 138.22B |
| September 04, 2026 | 140.49B |
| September 03, 2026 | 139.12B |
| September 02, 2026 | 137.95B |
| September 01, 2026 | 137.77B |
| August 31, 2026 | 135.99B |
| August 28, 2026 | 136.73B |
| Date | Value |
|---|---|
| August 27, 2026 | 135.12B |
| August 26, 2026 | 137.74B |
| August 25, 2026 | 136.62B |
| August 24, 2026 | 138.87B |
| August 21, 2026 | 139.44B |
| August 20, 2026 | 138.10B |
| August 19, 2026 | 140.44B |
| August 18, 2026 | 137.83B |
| August 17, 2026 | 135.92B |
| August 14, 2026 | 136.78B |
| August 13, 2026 | 135.90B |
| August 12, 2026 | 136.13B |
| August 11, 2026 | 136.03B |
| August 10, 2026 | 134.40B |
| August 07, 2026 | 131.52B |
| August 06, 2026 | 129.93B |
| August 05, 2026 | 130.02B |
| August 04, 2026 | 130.29B |
| August 03, 2026 | 130.91B |
| July 31, 2026 | 129.26B |
| July 30, 2026 | 130.26B |
| July 29, 2026 | 132.60B |
| July 28, 2026 | 131.76B |
| July 27, 2026 | 128.35B |
| July 24, 2026 | 127.06B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 196.37B |
| Becton, Dickinson & Co. | 64.10B |
| Boston Scientific Corp. | 73.85B |
| Intuitive Surgical, Inc. | 133.59B |
| Johnson & Johnson | 644.86B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.479B |
| Revenue (Quarterly) | 9.756B |
| Total Expenses (Quarterly) | 8.286B |
| EPS Diluted (Quarterly) | 1.144 |
| Gross Profit Margin (Quarterly) | 60.80% |
| Profit Margin (Quarterly) | 15.16% |
| Earnings Yield | 4.62% |
| Operating Earnings Yield | 6.60% |
| Normalized Earnings Yield | 5.052 |